DA Davidson Initiates Coverage on Mead Johnson (MJN) with a Neutral
More News related to MJN
- Bristol-Myers (BMY) To Spin-Off Mead Johnson (MJN) Holdings
- Mead Johnson to File Registration Statement; Comments on Bristol-Myers Squibb Announcement to Split-off Mead Johnson
- Mead Johnson Webcasts Investor Meeting
- Mead Johnson Nutrition (MJN) Prices Notes Offering
- Mead Johnson Nutrition Announces Pricing of Notes Offering
More News related to New Coverage
- Maxim Group Initiates Coverage on Golden Green Enterprises (CHOP) with a Buy
- Hilliard Lyons Initiates Coveage on Approach Resources (AREX) with a Buy
- Wells Fargo Transfers Coverage on Intuitive Surgical (ISRG) to a Market Perform; Raises Valuation Range
- Wedbush Initiates Coverage on Coinstar (CSTR) with an Outperform
- Thomas Weisel Starts FARO Tech. (FARO) at Overweight, $24 Price Target
DA Davidson initiates coverage on Mead Johnson (NYSE: MJN) with a Neutral rating.
To see more analyst ratings on MJN Click Here.
Mead Johnson Nutrition Company manufactures and markets infant formula and childrens nutrition products in North America, Latin America, Europe, and the Asia-Pacific.
Related Categories
New CoverageStocks Mentioned
+0.39Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
